)
Weichang Zhou, PhD
CTO
MediLink Therapeutics
Dr. Weichang Zhou is Chief Technology Officer of MediLink Therapeutics and a globally distinguished leader in cell culture engineering and biomanufacturing, with over 30 years of industry experience. He has held senior leadership roles at Merck, PDL BioPharma, Genzyme (Sanofi), and WuXi Biologics. His pioneering research, industrial innovation, and leadership have driven a number of publications, patents, and groundbreaking bioprocessing technologies. He earned his Ph.D. from the University of Hannover and conducted postdoctoral research at DECHEMA, ETH Zurich, and the University of Minnesota. He is a recipient of Asia-Pacific Biopharma Excellence Awards CTO of the Year 2023 award (2024), 2025 ECI Cell Culture Engineering Award, and 2025 ECI Integrated Continuous Biomanufacturing (ICB) Award. In 2026 he was elected to the National Academy of Engineering for engineering and leadership in the field of manufacturing and development of biologics.
Sessions
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}